- 1. MAG (myelin associated glycoprotein)
- [family of heavily glycosylated, NCAM-like membrane proteins that serve to glue the extracellular faces of myelin lamellae in tight apposition; transient expression may control the spiral wrapping of the myelin sheath around an axon. ( CSP )] (UMLS (CSP) C0129439) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine ;
=glycoprotein;
nerve/myelin protein | - 29. MAGNET REMOVAL CORNEA FB
- [ ] (UMLS (ICD9CM) C0844519) Magnetic removal of embedded foreign body from cornea =Therapeutic or Preventive Procedure
|
- 2. magainin
- [A class of antimicrobial peptides discovered in the skin of XENOPUS LAEVIS. They kill bacteria by permeabilizing cell membranes without exhibiting significant toxicity against mammalian cells. ( MSH )] (UMLS (CSP) C0597875) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 30. MAGNET REMOVE FB LENS
- [ ] (UMLS (ICD9CM) C0197743) =Therapeutic or Preventive Procedure
|
- 3. MAGE-1 Antigen
- [A cancer specific antigen expressed by the melanoma antigen gene. ( NCI )] (UMLS (NCI) C0126758) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 31. magnetic
- [processes and behaviors associated with magnetic fields. ( CSP )] (UMLS (CSP) C0563532) =Natural Phenomenon or Process =Physical Phenomenon;
=magnetic field;
biomagnetism;
|
- 4. MAGE-10.A2
- [A synthetic nonapeptide derived from a melanoma-associated antigen. Vaccination with MAGE-10.A2 may stimulate a host cytotoxic T-cell response against tumor cells that express the melanoma-associated antigen, resulting in tumor cell lysis. (NCI04) ( NCI )] (UMLS (NCI) C1134715) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 32. magnetic beads
- [ ] (UMLS (CSP) C1328924) =Natural Phenomenon or Process; ;
|
- 5. MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Sargramostim/tyrosinase peptide
- (UMLS (NCI) C1134658) =Therapeutic or Preventive Procedure
| - 33. magnetic colloid
- [ ] (UMLS (CSP) C0598192) =Biomedical or Dental Material
|
- 6. MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Tyrosinase peptide
- (UMLS (NCI) C1134657) =Therapeutic or Preventive Procedure
| - 34. magnetic field
- [portion of space near a magnetic body or a current-carrying body in which the magnetic forces due to the body or current can be detected. ( CSP )] (UMLS (CSP) C0563533) =Natural Phenomenon or Process =magnetic;
=TMS |
- 7. MAGE-12 Peptide Vaccine
- [A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an epitope recognized by tumor infiltrating lymphocytes (TIL). Vaccination with MAGE-12 peptide stimulates the host immune system to mount a TIL response against tumor cells expressing MAGE-12, potentially resulting in decreased tumor growth. ( NCI )] (UMLS (NCI) C0935670) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 35. Magnetic flux
- (UMLS (HL7) C1547031) =Quantitative Concept =Kind of quantity;
|
- 8. MAGE-12 peptide vaccine/Montanide ISA-51
- (UMLS (NCI) C0935671) =Therapeutic or Preventive Procedure
| - 36. magnetic recording system
- [ ] (UMLS (CSP) C0596877) =Intellectual Product ;
=biomedical automation;
|
- 9. MAGE-3
- [Expressed only in normal testis and placenta by human MAGEA3 Gene, MAGE-3.1 Antigen has an unknown function. (NCI) ( NCI )] (UMLS (NCI) C0962473) MAGE-3 Antigen;
MAGE-3.1 Antigen;
MAGEA3;
=Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 37. MAGNETIC RES IMAGE UNSP
- (UMLS (ICD9CM) C0024486) =Diagnostic Procedure ;
|
- 10. MAGE-3
- [A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma. (NCI04) ( NCI )] (UMLS (NCI) C1510427) MAGE-3.1;
Recombinant MAGE-3.1 Antigen =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 38. Magnetic resonance
- [Computed, Magnetic resonance ( HL7V3.0 )] (UMLS (HL7) C1551403) =Laboratory Procedure =ObservationMethod;
|
- 11. MAGE-3.1/PADRE 965.10
- (UMLS (NCI) C0879247) MAGE-3/PADRE 965.10;
=Therapeutic or Preventive Procedure | - 39. Magnetic Resonance
- [A physical phenomenon involving the interaction of atomic nuclei placed in an external magnetic field with an applied electromagnetic field oscillating at a particular frequency. Magnetic conditions within the material are measured by monitoring the radiation absorbed and emitted by the atomic nuclei. It is the underlying principle of Magnetic Resonance Imaging (MRI). ( NCI )] (UMLS (NCI) C0028580) =Natural Phenomenon or Process ;
|
- 12. MAGE-3/SB AS-2
- (UMLS (NCI) C0879284) =Therapeutic or Preventive Procedure
| - 40. Magnetic resonance angiography
- [Non-invasive method of vascular imaging and determination of internal anatomy without injection of contrast media or radiation exposure. The technique is used especially in CEREBRAL ANGIOGRAPHY as well as for studies of other vascular structures. ( MSH )] (UMLS (HL7) C0243032) =Diagnostic Procedure ;
=Modality;
|
- 13. MAGE12
- [This gene may be involved in carcinogenesis. ( NCI )] (UMLS (NCI) C1416973) MAGEA12 Gene;
Melanoma Antigen Family A, 12 Gene =Gene or Genome ◊ [Expressed only in normal testis by human MAGEA12 Gene (MAGE Family), 314-aa 35-kDa MAGE-12 Antigen is a tumor-specific antigen of unknown function recognized by autologous cytolytic T lymphocytes and containing a MAGE domain. (NCI) ( NCI )] (UMLS (NCI) C1449389) MAGE-12 Antigen; MAGEA12; Melanoma Antigen Family A 12; Amino Acid, Peptide, or Protein; Immunologic Factor | - 41. Magnetic Resonance Imaging
- (UMLS (HL7) C1552358) =Professional or Occupational Group =Radiologic Technologist;
|
- 14. MAGEA3
- [This gene may be involved in embryonal development. It may also play a role in carcinogenesis. ( NCI )] (UMLS (NCI) C0677907) =Gene or Genome ;
| - 42. magnetic resonance imaging
- [non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images; concept includes proton spin tomographic techniques. ( CSP )] (UMLS (NCI) C0024485) =Diagnostic Procedure ;
=imaging/visualization/scanning;
nuclear magnetic resonance spectroscopy =fMRI;
diffusion magnetic resonance imaging;
|
- 15. MAGED1
- [Encoded by MAGED1 Gene (MAGE Family), ubiquitous 778-amino acid 86-kD cytoplasmic NRAGE Protein contains a 200-amino acid MAGE homology domain. NRAGE appears to shift from cytoplasm to plasma membrane upon NGF stimulation to interact with p75NTR. NRAGE antagonizes p75NTR association with TRKA, inhibits cell cycle progression, and facilitates p75NTR-mediated apoptosis. NRAGE may regulate the function of DLX family members. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0960824) MAGE-D1 Antigen;
Melanoma-Associated Antigen D1;
NRAGE Protein;
PRO2292;
Urotrophin Receptor-Interacting MAGE Homolog Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 43. Magnetic Resonance Imaging (MRI)
- (UMLS (HL7) C1552430) =Intellectual Product ;
=Clinic/Center;
|
- 16. MAGED1
- [This gene is a member of the melanoma antigen gene family and facilitates cell death. ( NCI )] (UMLS (NCI) C1334472) MAGED1 Gene;
Melanoma Antigen Family D, 1 Gene =Gene or Genome | - 44. Magnetic Resonance Imaging (MRI)
- (UMLS (HL7) C1555766) =Intellectual Product =Internal Medicine;
|
- 17. maggot
- [ ] (UMLS (CSP) C0016386) =Invertebrate
| - 45. Magnetic resonance imaging of brain and brain stem
- [ ] (UMLS (ICD9CM) C0412675) =Diagnostic Procedure
|
- 18. Magnesium
- [A measurement of the magnesium in a biological specimen. ( NCI )] (UMLS (NCI) C0373675) =Laboratory Procedure
| - 46. Magnetic resonance imaging of chest and myocardium
- [ ] (UMLS (ICD9CM) C0202827) =Diagnostic Procedure
|
- 19. Magnesium Acetate Tetrahydrate
- [The hydrated acetate salt form of magnesium. Magnesium is a divalent cation essential for a number of biochemical processes involved in nerve signaling, bone mineralization and muscle contractions. About 350 enzymes involved in glycolysis and the Krebs cycle, formation of cyclic-AMP and ATP, cellular signal transduction and protein and nucleic acid synthesis are dependent on magnesium. ( NCI )] (UMLS (NCI) C0991847) MAGNESIUM ACETATE TETRAHYDRATE PREPARATION;
=Organic Chemical; Pharmacologic Substance ;
=Unclassified Ingredients;
Inactive Ingredient Preparations =MAGNESIUM ACETATE TETRAHYDRATE 32 MG/100ML;
MAGNESIUM ACETATE TETRAHYDRATE 54 MG | - 47. Magnetic resonance imaging of musculoskeletal structures
- (UMLS (ICD9CM) C0202673) =Diagnostic Procedure
|
- 20. MAGNESIUM CARBONATE
- (UMLS (NCI) C0065517) =Pharmacologic Substance; Inorganic Chemical ;
=[TN406] MAGNESIUM;
[PH000] PHARMACEUTICAL AIDS / REAGENTS =ASA 500MG/CA CARB/MG CARB/MG OXIDE TAB;
AL OH 150MG/ASA 325MG/MG OH 150MG TAB;
CORN STARCH/METHYLBENZETHONIUM CL 0.055% PWDR,TOP;
MAGNESIUM CARBONATE BLOCKS;
QUINAPRIL 10 MG / QUINAPRIL HYDROCHLORIDE ORAL TABLET, FILM COATED;
quinapril 20 MG Oral Tablet;
quinapril 5 MG Oral Tablet;
QUINAPRIL 40 MG ORAL TABLET;
MAGNESIUM CARBONATE 260 MG;
MAGNESIUM CARBONATE 137.3 MG/5ML;
MAGNESIUM CARBONATE 400 MG;
MAGNESIUM CARBONATE 400 MG/5ML;
MAGNESIUM CARBONATE 97 MG;
MAGNESIUM CARBONATE 105 MG;
MAGNESIUM CARBONATE 232 MG;
MAGNESIUM CARBONATE 350 MG/5ML;
MAGNESIUM CARBONATE 300 MG;
MAGNESIUM CARBONATE 200 MG;
MAGNESIUM CARBONATE 57 MG;
MAGNESIUM CARBONATE 34 MG;
MAGNESIUM CARBONATE 160 MG;
MAGNESIUM CARBONATE 130 MG;
MAGNESIUM CARBONATE 100 MG;
MAGNESIUM CARBONATE 120 MG;
MAGNESIUM CARBONATE 238 MG/5ML;
MAGNESIUM CARBONATE 137.5 MG/5ML;
MAGNESIUM CARBONATE 3.177 GM/100ML;
MAGNESIUM CARBONATE 41.7 MG | - 48. Magnetic resonance imaging of pelvis, prostate, and bladder
- [ ] (UMLS (ICD9CM) C0203122) =Diagnostic Procedure
|
- 21. MAGNESIUM CHLORIDE
- [Magnesium Chloride was used as a laxative. An alkaline earth metal, magnesium is important for many biochemical functions and reactions; for bone and muscle function, protein and fatty acid formation, activation of B vitamins, blood clotting, insulin secretion, and ATP formation. More than 300 enzymes require magnesium for catalytic action. The adult daily requirement is about 300 mg/day. Magnesium is found in many green plants, vegetables, and seeds; chlorophyll is a magnesium-centered porphyrin compound. Magnesium salts are used for magnesium deficiency supplementation. (NCI04) ( NCI )] (UMLS (NCI) C0024472) =Pharmacologic More…
| - 49. Magnetic resonance imaging of spinal canal
- [ ] (UMLS (ICD9CM) C0177803) =Diagnostic Procedure
|
- 22. MAGNESIUM CLOFIBRATE
- (UMLS (NCI) C0771940) =Organic Chemical; Pharmacologic Substance ;
| - 50. Magnetic resonance spectroscopy
- [Magnetic resonance spectroscopic imaging. A noninvasive imaging method that provides information about cellular activity (metabolic information). It is used along with magnetic resonance imaging (MRI) which provides information about the shape and size of the tumor (spatial information). ( NCI )] (UMLS (HL7) C0024487) =Diagnostic Procedure ;
=Modality;
|
- 23. magnesium deficiency
- [condition due to decreased dietary intake of magnesium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss; deficiency causes irritability of the nervous system with tetany, vasodilation, convulsions, tremors, depression, and psychotic behavior. ( CSP )] (UMLS (CSP) C0024473) =Disease or Syndrome ;
=Deficiency Diseases;
dietary deficiency;
metal metabolism disorder;
| - 51. magnetic therapy
- [ ] (UMLS (CSP) C0872210) =Therapeutic or Preventive Procedure ;
|
- 24. MAGNESIUM HYDROXIDE
- [A solution of magnesium hydroxide with antacid and laxative properties. Milk of magnesium exerts its antacid activity in low doses such that all hydroxide ions that enter the stomach are used to neutralize stomach acid. This agent exerts its laxative effect in higher doses so that hydroxide ions are able to move from the stomach to the intestines where they attract and retain water, thereby increasing intestinal movement (peristalsis) and inducing the urge to defecate. ( NCI )] (UMLS (NCI) C0024476) =Pharmacologic Substance; Inorganic Chemical =Hydroxides;
[TN406] MAGNESIUM;
Magnesium Compounds;
[GA202] HYPEROSMOTIC LAXATIVES;
[GA108] MAGNESIUM CONTAINING ANTACIDS;
=magaldrate;
aluminum magnesium hydroxide;
AL OH 150MG/ASA 325MG/MG OH 150MG TAB;
CASCARA/MAGNESIUM HYDROXIDE CONC SUSP;
NEPRO LIQUID VANILLA;
MAGNESIUM HYDROXIDE 160 MG;
MAGNESIUM HYDROXIDE 200 MG;
MAGNESIUM HYDROXIDE 300 MG;
MAGNESIUM HYDROXIDE 311 MG;
MAGNESIUM HYDROXIDE 200 MG/5ML;
MAGNESIUM HYDROXIDE 400 MG;
MAGNESIUM HYDROXIDE 300 MG/5ML;
MAGNESIUM HYDROXIDE 75 MG;
MAGNESIUM HYDROXIDE 80 MG;
MAGNESIUM HYDROXIDE 400 MG/5ML;
MAGNESIUM HYDROXIDE 103 MG/5ML;
MAGNESIUM HYDROXIDE 325 MG;
MAGNESIUM HYDROXIDE 165 MG;
MAGNESIUM HYDROXIDE 50 MG;
MAGNESIUM HYDROXIDE 450 MG/5ML;
MAGNESIUM HYDROXIDE 225 MG/5ML;
Magnesium Hydroxide 16 MG/ML;
MAGNESIUM HYDROXIDE 130 MG;
MAGNESIUM HYDROXIDE 5 MG;
MAGNESIUM HYDROXIDE 450 MG/ML;
MAGNESIUM HYDROXIDE 128 MG;
MAGNESIUM HYDROXIDE 100 MG;
Magnesium Hydroxide 120 MG/ML;
MAGNESIUM HYDROXIDE 1200 MG/5ML;
MAGNESIUM HYDROXIDE 350-425 MG/5ML;
| - 52. magnetoencephalography
- [measurement of magnetic activity of the brain, usually conducted externally by sensitive devices such as SQUID's; electric currents generated in the brain by neural activity are accompanied by orthogonal magnetic fields and the measurement of these fields provide information about the localization of brain activity which is complementary to that provided by electroencephalography. ( CSP )] (UMLS (CSP) C0024489) =Diagnostic Procedure ;
=encephalography;
biomagnetism measurement |
- 25. magnesium ion
- [divalent cation of magnesium essential in nutrition. ( CSP )] (UMLS (CSP) C0596876) =Biologically Active Substance; Element, Ion, or Isotope =ion;
| - 53. magnetometry
- [ ] (UMLS (CSP) C0024490) =Occupational Activity ;
|
- 26. MAGNESIUM TRISILICATE
- (UMLS (NCI) C0065533) =Pharmacologic Substance; Inorganic Chemical ;
=[TN406] MAGNESIUM;
Magnesium Silicates;
[GA108] MAGNESIUM CONTAINING ANTACIDS;
=MAGNESIUM TRISILICATE 20 MG;
magnesium trisilicate 250 MG;
MAGNESIUM TRISILICATE 400 MG/5ML;
MAGNESIUM TRISILICATE 455 MG;
MAGNESIUM TRISILICATE 40 MG;
| - 54. Magnifier
- [An optical device that enlarges the apparent size of an image or object. ( NCI )] (UMLS (NCI) C0445078) =Medical Device ;
|
- 27. MAGNET REMOV ANT SEG FB
- [ ] (UMLS (ICD9CM) C0197593) =Therapeutic or Preventive Procedure
| - 55. Magnocellular Nevus
- [A benign melanocytic proliferation within or adjacent to the optic disk. It presents as a pigmented, intraocular tumor. ( NCI )] (UMLS (NCI) C0334431) =Neoplastic Process
|
- 28. MAGNET REMOV POST SEG FB
- [ ] (UMLS (ICD9CM) C0197806) =Therapeutic or Preventive Procedure
| - 56. MAGUK Family Gene
- [Membrane-Associated Guanylate Kinase Family Genes encode MAGUK (Membrane-Associated GUanylate Kinase homolog) proteins containing DHR, SH3, and C-terminal GK-like domains. MAGUKs include Drosophila lethal(1)discs large-1 tumor suppressor protein (dlg1); mammalian Zo-1 tight junction protein; mammalian synaptic proteins that seem to interact with the cytoplasmic tail of NMDA receptor subunits (SAP90/PSD-95, CHAPSYN-110/PSD-93, SAP97/DLG1 and SAP102); 55 kD erythrocyte membrane protein (p55); C. elegans lin-2 protein; rat CASK protein; and human DLG2 and DLG3 proteins. An N-terminal ATP-binding site (P-loop) of Guanylate Kinase is not conserved in the MAGUK GK-like domain; MAGUKs do retain residues known in GK to bind GMP. (NCI) ( NCI )] (UMLS (NCI) C1334692) Membrane-Associated Guanylate Kinase Family Gene;
=Gene or Genome |
home
